Stifel Financial’s SQZ Biotechnologies Company SQZ Stock Holding History

Stifel Financial’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-851,520	Closed	-$230K	–	3456
2023 Q2	$230K	Sell	851,520 -22,806	-3%	-$12.9K	﹤0.01%	2968
2023 Q1	$490K	Sell	874,326 -161,232	-16%	-$119K	﹤0.01%	2523
2022 Q4	$766K	Buy	1,035,558 +545,352	+111%	+$1.19M	﹤0.01%	2194
2022 Q3	$1.12M	Buy	490,206 +25,174	+5%	+$75.5K	﹤0.01%	1891
2022 Q2	$1.48M	Buy	465,032 +290,063	+166%	+$1.04M	﹤0.01%	1708
2022 Q1	$842K	Buy	+174,969	New	+$1.11M	﹤0.01%	2242

Other funds holding SQZ

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

BSB

Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Stifel Financial's SQZ Position: Q3 2023 in Review

Stifel Financial sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 851,520 shares — an estimated $230K sold.

Stifel Financial first reported a position in SQZ in Q1 2022 and held it in 6 quarters. The position peaked at $1.48M in Q2 2022. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

Stifel Financial reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
Stifel Financial sold 851,520 SQZ Biotechnologies Company shares in Q3 2023, an estimated $230K.
Stifel Financial first reported a position in SQZ Biotechnologies Company in Q1 2022 and held it in 6 quarters.
Stifel Financial's SQZ Biotechnologies Company position peaked at $1.48M in Q2 2022.
5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Stifel Financial's 13F filing for Q3 2023, filed 13 Nov 2023.